Events

Below is a list of events where CELT researchers and staff are presenting CELT research, or events that CELT is endorsing.

CELT's Community of Practice for Long-acting therapeutics for maternal and paediatric health

1 July 2025, The Spine, Liverpool UK

There is still time to register. To attend this meeting, please email our Stakeholder Engagement Coordinator, Rachel Daley.

Agenda

09:00	Registration
09:30	Welcome and Overview - Professor Andrew Owen
Session 1: Long-acting therapeutics in maternal health		Chair: Ethel Weld
09:35	Sharon Nachman IMPAACT Network	Maternal health priorities – Identifying where the need is greatest
09:55	Rachel Scott MedStar Health Research Institute/ IMPAACT Network	Pharmacokinetics and safety considerations for long-acting therapeutics: use during pregnancy and breastfeeding
10:15	Dr Adeniyi Olagunju CELT Perinatal Pharmacology Group University of Liverpool	Long-acting therapeutic technologies and innovations: potential applications for women’s health priorities
10:35	Discussion
11:00	Refreshment break
Session 2: Long-acting therapeutics in paediatric health		Chair: Rachel Daley
11:20	Professor Moherndran Archary University of Kwa-Zulu Natal	Paediatric health priorities – Identifying where the need is greatest
11:40	Edmund Capparelli University of California, San Diego	Pharmacokinetics and safety considerations for long-acting therapeutics: use in children
12:00	Prajith Venkatasubramanian CELT Perinatal Pharmacology Group University of Liverpool	Long-acting therapeutic technologies and innovations: potential applications for paediatric health priorities
12:20	Discussion
12:45	Lunch
Session 3: Long-acting therapeutics in global health		Chair: Grace Miheso
13:45	Martina Penazzato World Health Organisation	Partnering across the end to end to address the needs of underrepresented populations
13:55	Brighton Mphako – SAHPRA Patrick GAD – Rwanda FDA Nathaniel Nana Kwabena Nkrumah – Ghana FDA Kim Struble - FDA	Panel discussion: Enabling long-acting therapeutics development and use for maternal and paediatric health through regulation
14:40	Andre Tchouatieu - MMV Brenda Okware - Gilead	Lessons from a real-world long-acting development programme
15:20	Refreshments break
Breakout Sessions		Chair: Rachel Daley
15:40	Sessions: Maternal – Dr Odula Paediatric - Mili Karina Regulatory/ethics – Osei Boateng Access – Pierre Gashema	Each breakout session will synthesise learning from the workshop and recommend action plans for progress that will feed into a white paper.
16:25	Refreshment break
16:35	Breakout sessions feedback	Summary of discussion from each breakout session by rapporteur (5 mins each)
16:55	Closing remarks by Dr Adeniyi Olagunju
17:00	Close

Community of Practice context

Significant gaps currently exist in the development of new medicines for women of child-bearing age and children, compared with the general adult population. This gap could expand further with new treatment modalities like long-acting therapeutics. Additionally, the extent of breastfed infant exposure through breast milk is largely unknown.

The overarching aim of this community of practice (funded by global health agency Unitaid) is to catalyse the development and availability of long-acting therapeutics of value for maternal and paediatric health globally, including in low- and middle- income countries.

This will be achieved through the following specific objectives:

1. Engaging relevant stakeholders in academia, clinical practice, pharmaceutical industry, regulators, women and patient groups
2. Synthesise evidence-based perspectives on best practices for long-acting therapeutics
3. Disseminate outputs from the community of practice for uptake by the wider community.

There are 9 meetings for the community of practice in 2025 (2 full community of practice meetings online (one has already occurred), 1 in person workshop and 6 shorter webinars (one has already occurred)). The next online session will be held on Wednesday 4 June, 2025.

To join the Community of Practice and attend this meeting, please fill in this Expression of Interest form to receive an invite link.

We will use this Events page to keep you updated on the remaining events, so please check back. Members are welcome to join the community of practice at any point.

British Society for Nanomedicine 2025 Annual Meeting

2-3 September 2025, Queens University Belfast Ireland

With four incredible keynote speakers, this two day event includes presentations (with an emphasis on early career researchers, industry and academic taskforce meetings, workshops, and discussion groups.

Find out more including how to register and submit an abstract via the BSNM Annual Meeting event page.

Abstract submission deadline: 7 July 2025
Registration deadline: 11 July 2025

26th International workshop on clinical pharmacology of HIV, hepatitis and other antiviral drugs 2025

3-4 September 2025, Amsterdam The Netherlands

CELT are an official endorser to the 26th Antiviral Workshop 2025, set to take place on 3-4 September in Amsterdam, the Netherlands.

This prestigious workshop brings together leading experts, researchers, and professionals from the field of clinical pharmacology to exchange knowledge, share insights, and discuss the latest therapeutic advancements for HIV, hepatitis, and other antiviral drugs.

Find out more information, including how to register and submit an abstract on the Antiviral Workshop 2025 event page.

INHSU 2025: International Conference on Health and Hepatatis in Substance Users

14-17 October 2025, CapeTown South Africa

This year's conference around health and hepatitis in substance users that meaningfully involves people who use drugs is back in its home city for the first time in five years. Dr Marcia Vermeulen from the University of Cape Town will be presenting a talk on some exciting community engagement research for the LONGEVITY project.

For more information including booking, please head to the INHSU 2025 conference page.
(Early bird tickets available until 27 July)

---

Previous events

LEAP | New Approaches to Bioequivalence Assessment and Generic Approvals for Long Acting/Extended Release Antiretroviral Formulations

Find all the recordings from the workshop talks here.

LEAP | Long-acting Tuberculosis Drug Development Workshop 2024 - 15 April 2024

Watch CELT co-Director Prof. Andrew Owen's presentation here.

Find all the recordings from the workshop here.

19th Residential Course on Clinical Pharmacology and Antiretrovirals - 17-19 January 2024

Download the presentation decks here

LEAP | Investigator Meeting & Annual Workshop 2023 - 18 February 2023

Update from LONGEVITY delivered by Professor Andrew Owen

Access the full workshop here

LEAP | Investigator Meeting & Annual Workshop 2022 - 12 February 2022

Update from the LEAP Modeling and Simulation Core delivered by Professor Andrew Owen

Update from LONGEVITY delivered by Professor Andrew Owen

Access the full workshop here

LEAP | Investigator Meeting & Annual Workshop 2021 - 5 March 2021

Update from the LEAP Modeling and Simulation Core delivered by Dr Marco Siccardi

Update from LONGEVITY delivered by Professor Andrew Owen

Access the full workshop here

Liverpool Masterclass in Antiretroviral Pharmacology (LMAP) 11 November 2020

PBPK Modelling: No escape from reality delivered by Dr Marco Siccardi

Long-acting antiviral therapy: Life in the slow lane delivered by Professor Andrew Owen